Javier Varona Santos

Javier Varona Santos

Auto-generated profile, based on publicly available information

Javier Varona Santos

Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami, Miller School of Medicine, Miami, Florida

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
Alla MitrofanovaAlla Mitrofanova
Alla Mitrofanova
AFAntonio Fontanella
Antonio Fontanella
MTMatthew Tolerico
Matthew Tolerico
SMShamroop Mallela
Shamroop Mallela
JDJudith Molina David
Judith Molina David
AFAlessia Fornoni
Alessia Fornoni
Background: The signaling molecule stimulator of IFN genes (STING) was identified as a crucial regulator of the DNA-sensing cyclic GMP-AMP synthase (cGAS)-STING pathway, and this signaling pathway regulates inflammation and energy homeostasis under conditions of obesity, kidney fibrosis, and AKI. However, the role of STING in causing CKD, including diabetic kidney disease (DKD) and Alport syndrome, is unknown. Methods: To investigate whether STING activation contributes to the development and progression of glomerular diseases such as DKD and Alport syndrome, immortalized human and murine podocytes were differentiated for 14 days and treated with a STING-specific agonist. We used diabetic db/db mice, mice with experimental Alport syndrome, C57BL/6 mice, and STING knockout mice to assess the role of the STING signaling pathway in kidney failure. Results: In vitro, murine and human podocytes express all of the components of the cGAS-STING pathway. In vivo, activation of STING renders C57BL/6 mice susceptible to albuminuria and podocyte loss. STING is activated at baseline in mice with experimental DKD and Alport syndrome. STING activation occurs in the glomerular but not the tubulointerstitial compartment in association with autophagic podocyte death in Alport syndrome mice and with apoptotic podocyte death in DKD mouse models. Genetic or pharmacologic inhibition of STING protects from progression of kidney disease in mice with DKD and Alport syndrome and increases lifespan in Alport syndrome mice. Conclusion: The activation of the STING pathway acts as a mediator of disease progression in DKD and Alport syndrome. Targeting STING may offer a therapeutic option to treat glomerular diseases of metabolic and nonmetabolic origin or prevent their development, progression, or both.

2 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMatthew B. Wright
Matthew B. Wright
JSJavier Varona Santos
Javier Varona Santos
CKChristian Kemmer
Christian Kemmer
CMCyrille Maugeais
Cyrille Maugeais
JCJean-Philippe Carralot
Jean-Philippe Carralot
AFAlessia Fornoni
Alessia Fornoni
Impaired cellular cholesterol efflux is a key factor in the progression of renal, cardiovascular, and autoimmune diseases. Here we describe a class of 5-arylnicotinamide compounds, identified through phenotypic drug discovery, that upregulate ABCA1-dependent cholesterol efflux by targeting Oxysterol Binding Protein Like 7 (OSBPL7). OSBPL7 was identified as the molecular target of these compounds through a chemical biology approach, employing a photoactivatable 5-arylnicotinamide derivative in a cellular cross-linking/immunoprecipitation assay. Further evaluation of two compounds (Cpd A and Cpd G) showed that they induced ABCA1 and cholesterol efflux from podocytes in vitro and normalized proteinuria and prevented renal function decline in mouse models of proteinuric kidney disease: Adriamycin-induced nephropathy and Alport Syndrome. In conclusion, we show that small molecule drugs targeting OSBPL7 reveal an alternative mechanism to upregulate ABCA1, and may represent a promising new therapeutic strategy for the treatment of renal diseases and other disorders of cellular cholesterol homeostasis.

3 February 2022 in Genes & Diseases
Verified
Journal Article
Open access
SMShamroop Kumar Mallela
Shamroop Kumar Mallela
MGMengyuan Ge
Mengyuan Ge
JMJudith Molina
Judith Molina
JSJavier Varona Santos
Javier Varona Santos
JKJin-ju Kim
Jin-ju Kim
AFAlessia Fornoni
Alessia Fornoni